Neals Als, Scores decline with disease progression at a rate that is generally consistent across clinical trials. S. ALS is a uniquely human disease, and investigations into the causes and possible treatments cannot be done without the participation of people living with the disease. In 1995, the Northeast ALS Consortium (NEALS) was founded as an independent, non-profit group of research sites that collaboratively conduct clinical research in ALS and other motor neuron diseases. Or rather, make that a global network of dedicated doctors and scientists. The HEALEY ALS Platform Trial is a collaborative effort and enrollment in the trial is available at several sites across the U. (MTPA) today announced that eight poster presentations highlighting new research in amyotrophic lateral The objective of this study was to establish a large multicenter retrospective longitudinal registry of PLS patients seen at Northeast ALS Consortium (NEALS) sites to better characterize the natural progression of PLS. to bring the trial close to people who want to participate. You can locate both interventional trials, which examine if an experimental treatment is effective and safe under controlled environments, and observational trials, which examine The Northeast ALS Consortium (NEALS) provides the most accurate and up-to-date resource for information on both federally and privately funded clinical studies focusing on ALS and other similar motor neuron diseases. Join us as we continue to The NEALS network has 30 years of experience developing and conducting multi-center clinical trials in ALS and motor neuron disease. Its commitment to partnerships, patient-focused approaches, and community engagement continues to offer hope and drive progress for ALS ALS usually occurs in the absence of a family history of the disease (sporadic ALS), though about 10% of affected persons have a close relative with ALS (familial ALS). Northeast ALS Consortium (NEALS). The NEALS Consortium is an active network of trial-ready sites with extensive experience in designing and managing FDA-regulated clinical trials for ALS. The ALSFRS-R is a simple, validated, and reliable tool for evaluating decline in function. 1,2 ~ Prilenia and Ferrer will unveil their planned pivotal Phase 3 study of pridopidine in ALS at the upcoming Northeast Amyotrophic Lateral Sclerosis Consortium (NEALS) 2025 Annual Meeting, Florida, October 7-10, 2025 Aimed at confirming the encouraging post hoc Phase 2 data for pridopidine in global Games, visualizations, interactives and other weird stuff. search our sites Our Membership NEALS member sites are medical institutions equipped to perform research and clinical trials in Amyotrophic Lateral Sclerosis (ALS) and motor neuron diseases. Topics include updates on clinical trials, best practices for clinical care and current research efforts in ALS causes and treatments. The Network for Excellence in ALS (NEALS) is an international group with over 150 member sites, including centers in Japan, Israel, Mexico, Canada,… Community Education Webinars In partnership with The ALS Association, NEALS offers a variety of educational webinars for the ALS community. This conference offers a platform for networking and discussions, providing attendees with insights from esteemed leaders in the field. In the field of amyotrophic lateral sclerosis (ALS), the Northeast ALS Consortium (NEALS) is the hands-down Join a Leading Network of ALS Researchers and Clinicians A NEALS membership connects you with a collaborative network of ALS researchers, and clinicians. It takes a village to stage a high-power clinical trial for neurodegenerative disease. You can locate both interventional trials, which examine if an experimental treatment is effective and safe under controlled environments, and observational trials, which examine Looking to become more active in NEALS? Join a NEALS Committee! NEALS has launched multiple committees dedicated to enhancing ALS research and patient care. All sites are part of the NEALS Consortium. ALS usually occurs in the absence of a family history of the disease (sporadic ALS), though about 10% of affected persons have a close relative with ALS (familial ALS). Hi! I'm Neal. NEALS has a repository of serum, plasma, cerebrospinal fluid (CSF), whole blood, extracted DNA, and urine samples from NEALS and NCRI research studies of amyotrophic lateral sclerosis (ALS) and motor neuron disease. Samples from this repository are available to researchers for the purpose of furthering the Check your internet and refresh this page. Governed by a seasoned Leadership Team, NEALS has successfully partnered with industry and academic researchers to conduct high-quality ALS studies for over 25 years and has grown to be the The Annual NEALS Meeting brings together researchers, clinicians, industry leaders, and individuals with lived ALS experience to discuss the latest advancements in ALS research and treatment.